Your fat cells contain an enzyme whose main job, as best researchers can tell, is to keep those cells in a low-energy, storage-friendly state. It is called NNMT, and 5-Amino-1MQ exists for essentially one reason: to switch it off. That is the whole idea. It is not a fat burner. It is a brake release.
What it actually is
First, a category note that trips a lot of people up. 5-Amino-1MQ is sold right alongside research peptides, but it is not a peptide. It is a small synthetic molecule, tiny even by drug standards, and it works in a completely different way than something like BPC-157 or MOTS-c. Peptides tend to mimic or amplify signals your body already sends. This one does a single mechanical thing: it blocks an enzyme.
That enzyme, NNMT, sits mostly in your body fat and your liver. Its day job is to use up a key molecule involved in metabolic signaling, and a side effect of that activity is that NAD+ (a molecule your cells need for energy production) gets depleted in fat tissue. When NAD+ runs low, fat cells essentially idle. They store rather than burn. When 5-Amino-1MQ blocks NNMT, NAD+ levels recover, and in the studies done so far, the fat cells start behaving like more metabolically active cells again.
Why women are paying attention
You will mostly hear about 5-Amino-1MQ in the biohacking and bodybuilding world, framed as a fat-loss compound. That framing is not wrong, but it skips the part that I find more interesting for women in midlife.
Two things line up here. The first is that NNMT activity tends to climb with age and runs higher in people carrying more body fat. So the very enzyme this compound targets is one that may be working harder against you in exactly the years when body composition starts shifting for reasons that feel disconnected from anything you are actually doing. That is not proof it will help. But it explains why the target itself resonates with women who feel like the old rules stopped working around perimenopause.
The second is muscle, and this is the part almost no one talks about. In one study, researchers gave the compound to very old mice and found it reactivated the muscle repair cells that normally go quiet with age, leading to better recovery and larger muscle fibers after injury. Women lose muscle faster around and after menopause, and muscle is the tissue that protects metabolism, strength, and independence as we age. A compound that touches both fat metabolism and muscle repair is a different conversation than "it helps you lean out."
What the research actually shows
Here is the honest version, and it matters: everything we know so far comes from studies in mice and cells, not people.
In obese mice, the foundational 2018 work found reduced body weight, less body fat, and smaller fat cells, and notably the mice did not eat less to get there. A 2024 study gave it across several doses and saw dose-dependent improvements in blood sugar control and insulin sensitivity, plus less fat in the liver. The 2019 muscle study is the aging-and-regeneration result above. A 2022 study found that pairing it with eating less normalized body fat faster than dieting alone and shifted the gut bacteria in the process. And the whole rationale traces back to a 2014 paper in Nature showing that turning NNMT down protected mice from diet-induced obesity in the first place.
Across those studies the signals are consistent, which is genuinely encouraging. Body weight, body fat, blood sugar, and muscle recovery all moved in the same direction. The mechanism is coherent and well supported. The gap is the jump from "this works in mice" to "this will do something for you."
The honest part
There are no published human trials as of 2026. None. Any dosing protocol you see passed around online is extrapolated from mouse studies, which is a rough translation at best.
It gets narrower. Almost all of the experimental work comes from a single research group. That is not a knock on the science, but independent replication by other labs is part of how a finding earns confidence, and that broader confirmation has not happened yet. We also have no human safety data, short-term or long-term, and nothing at all on how this compound might interact with the hormonal shifts of perimenopause, with medications, or with the specific metabolic picture of a woman in her 40s or 50s.
One practical note if you are researching this market: counterfeiting and mislabeling are real problems with newer compounds like this one. A certificate of analysis from a third-party lab is the minimum floor, not a nice-to-have. If you are considering 5-Amino-1MQ for any reason, that is a conversation for a healthcare provider who knows your full picture, not something to sort out from a forum thread.